drugset / Trial / NCT07436221
A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK139 in the treatment of participants with moderate to severe asthma.
Timeline
- Start
- 2026-02-28
- Primary completion
- 2026-12-27
- Completion
- 2027-02-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AK139 | Unknown | — | Subcutaneous |